Skip to main content

Amaroq Therapeutics

Auckland, New Zealand

Amaroq Therapeutics is a biotech firm developing cancer therapies targeting long non-coding RNAs.

$9.7M raised
Jul 2021
Seed

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Amaroq Therapeutics

How much funding has Amaroq Therapeutics raised?
Amaroq Therapeutics has raised $9.7M in total funding. The most recent round was Seed. The last funding was announced in July 2021.
Who are Amaroq Therapeutics's investors?
Amaroq Therapeutics's investors include Brandon Capital, Booster, Otago Innovation, Cure Kids Ventures.
Where is Amaroq Therapeutics headquartered?
Amaroq Therapeutics is headquartered in Auckland, New Zealand.
What does Amaroq Therapeutics do?
Amaroq Therapeutics is a biotech firm developing cancer therapies targeting long non-coding RNAs.
What stage is Amaroq Therapeutics at?
Amaroq Therapeutics is at the Seed stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Amaroq Therapeutics — Funding & Investors." VCBacked, July 8, 2021, https://www.vcbacked.co/company/amaroq-therapeutics. Accessed July 2, 2026.
APA
VCBacked. (2021). Amaroq Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/amaroq-therapeutics
Wikipedia (cite web)
{{cite web |title=Amaroq Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/amaroq-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .